Press-release for stocks related to nasdaq

LivePerson Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 23:00) - prnewswire.com
LPSN | $0.5099 -8.57% -9.37% 4.4M

| -95.24% | O: 0.25% H: 0.0% C: -5.73%
nasdaq grants

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 23:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K

| 75.16% | O: -0.44% H: 0.28% C: -2.92%
nasdaq grants

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 23:00) - globenewswire.com
FULC | $6.86 -2.83% -2.92% 560K

| 8.99% | O: -0.46% H: 1.53% C: -4.29%
nasdaq grants therapeutics

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 22:00) - globenewswire.com
SLDB | $8.7 -6.05% -6.44% 110K

| 54.64% | O: 0.0% H: 0.0% C: -2.32%
IBIO | $1.72 -2.83% 0.0% 95K

| 5.36% | O: -0.6% H: 2.4% C: -4.19%
nasdaq grants

Hepion Pharmaceuticals, Inc. Granted 180-day Extension by Nasdaq to Meet the Minimum Bid Price Requirements
Published: 2022-12-05 (Crawled : 22:00) - contravir.com
HEPA | News | $2.11 -0.09% -0.09% 73K

| -72.32% | O: -2.91% H: 4.68% C: 1.92%
nasdaq extension granted

Nasdaq November 2022 Volumes
Published: 2022-12-05 (Crawled : 22:00) - globenewswire.com
NDAQ | $60.35 0.47% 0.46% 3.1M

| -11.57% | O: -0.03% H: 0.38% C: -1.22%
nasdaq

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 21:00) - ir.auriniapharma.com
AUPH | $5.01 4.16% 3.99% 1.6M

| -2.04% | O: -0.2% H: 0.61% C: -2.45%
nasdaq grants

Nasdaq Completes Migration of the First U.S. Options Market to AWS
Published: 2022-12-05 (Crawled : 16:00) - globenewswire.com
NDAQ | $60.35 0.47% 0.46% 3.1M

| -13.0% | O: -0.33% H: 0.1% C: -1.29%
nasdaq market

WISeKey Celebrates Third Listing Anniversary on the NASDAQ
Published: 2022-12-05 (Crawled : 14:20) - globenewswire.com
WKEY | $2.18 2.68% 18K

| 74.86% | O: 0.56% H: 2.23% C: -1.68%
nasdaq

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2022
Published: 2022-12-05 (Crawled : 13:00) - biospace.com/
KALV | $11.59 0.78% 0.78% 350K

| 116.54% | O: -0.19% H: 0.37% C: -3.72%
pharmaceuticals nasdaq grants

Nasdaq Grants Windtree Therapeutics 180-day Extension to Regain Compliance
Published: 2022-12-05 (Crawled : 13:00) - globenewswire.com
WINT | $0.3419 0.62% 0.61% 470K

| -97.03% | O: -2.13% H: 8.64% C: -3.37%
nasdaq extension grants therapeutics

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-12-05 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K

| 116.54% | O: -0.19% H: 0.37% C: -3.72%
pharmaceuticals nasdaq grants